Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
BioAge CEO's big plans for 'multi-disease impact' of NLRP3 drug
After axing its lead obesity asset, BioAge has turned its attention to attacking inflammation in its pursuit of treatments for aging-related illnesses
Will Maddox
May 14, 2026 11:00am
Biogen advances Alzheimer’s tau program despite midphase miss
May 14, 2026 8:35am
MRD as a Decision Engine: Rethinking Oncology Trial Design
Brought to you by
Syneos Health
Regenxbio reaps pivotal win for Duchenne gene therapy
May 14, 2026 7:25am
Aptose exits cancer pact after Hanmi buyout blocks development
May 14, 2026 6:35am
AC Immune CEO bids adieu—Chutes & Ladders
May 15, 2026 8:30am
More News
Alumis pulls back from would-be rival to Amgen’s Tepezza
May 15, 2026 3:44am
Aardvark to dig into phase 3 data early after FDA imposes hold
May 15, 2026 1:51am
Signant Health buys Ametris to unite data streams in trials
May 14, 2026 1:27pm
Fierce Pharma
Biopharma rallies behind Pazdur to lead FDA. But is he willing?
May 14, 2026 11:05am
See more stories